Drug
I Dxd
I Dxd: highest development phase Phase 1/2, developed by Merck. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Merck
Trials
| Drug | Phase | Indication |
|---|---|---|
| I-DXd NCT07405151 | Phase 1/2 | Oesophageal Squamous Cell Carcinoma |
Latest
No recent events.
Follow I Dxd on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.